rewirebio.iobenchmarks
Dataset

Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)

Validation cohort from the same centres, collected 2024-2025, used for model selection.

Evaluation results

3 evaluations · 10 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.884 AUROC (low-TF (< 3%) cancers vs non-cancer)
unitless · higher

Uncertainty: 95% CI 0.868 to 0.901. Method not stated

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P14, sentence 5
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.917 AUROC (all cancers vs non-cancer)
unitless · higher

Uncertainty: 95% CI 0.905 to 0.929. Method not stated

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P14, sentence 1
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.61 Recall (sensitivity, all cancers, at the predefined cutoff (98% specificity in the training cohort))
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P14, sentence 3
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.397 Recall (sensitivity, low-TF (< 3%) stage I/II cancers, at the predefined cutoff (98% specificity in the training cohort))
fraction · higher

Uncertainty: 95% CI 0.350 to 0.445. Method not stated

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Supplementary Table S4, row 'Validation' / 'I/II', column 'Sensitivity (95% CI)'
Configuration: Fragmentia-AI WGS, high/medium/low-TF sequential fine-tuning (final model)Protocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.683 Recall (sensitivity, low-TF (< 3%) stage III/IV cancers, at the predefined cutoff (98% specificity in the training cohort))
fraction · higher

Uncertainty: 95% CI 0.594 to 0.763. Method not stated

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium/low-TF sequential fine-tuning (final model) on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Supplementary Table S4, row 'Validation' / 'III/IV', column 'Sensitivity (95% CI)'
Configuration: Fragmentia-AI WGS, high/medium-TF sequential fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.702 AUROC (low-TF (< 3%) cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high/medium-TF sequential fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 4
Configuration: Fragmentia-AI WGS, high-TF-only fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.988 AUROC (high-TF (> 5%) cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high-TF-only fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 2
Configuration: Fragmentia-AI WGS, high-TF-only fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.652 AUROC (low-TF (< 3%) cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high-TF-only fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 2
Configuration: Fragmentia-AI WGS, high-TF-only fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.905 AUROC (medium-TF (3-5%) cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high-TF-only fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 2
Configuration: Fragmentia-AI WGS, high-TF-only fine-tuningProtocol: Fragmentia-AI WGS paper: Internal validation cohort by ichorCNA tumour fraction
Dataset: Fragmentia-AI WGS internal validation cohort (2,043 samples, 0.1x ULP-WGS)
0.769 AUROC (all cancers vs non-cancer)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Fragmentia-AI WGS high-TF-only fine-tuning on the internal validation cohort by ichorcna tumour fraction

ctdnalit-20261011-fragmentiawgs2026-protocol-validation

Aggregation: Not reported

Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences; Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9) · Results P13, sentence 2

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

20 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Assay
ULP-WGS of plasma cfDNA, about 0.1x, DNBSEQ-T7
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
ULP-WGS of plasma cfDNA, about 0.1x, DNBSEQ-T7
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Negatives
1149
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Negatives
1149
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
Cancer and non-cancer samples (Table S1); low-TF cancers 62.3% of cancers Table S1: 894 cancers and 1,149 non-cancer controls.
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
Cancer and non-cancer samples (Table S1); low-TF cancers 62.3% of cancers Table S1: 894 cancers and 1,149 non-cancer controls.
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Positives
894
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Positives
894
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
Retrospective Geneseeq repository samples, first baseline pretreatment sample per person; 17 cancer types; tumour fraction by ichorCNA. Used for hyperparameter optimisation and model selection.
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
Retrospective Geneseeq repository samples, first baseline pretreatment sample per person; 17 cancer types; tumour fraction by ichorCNA. Used for hyperparameter optimisation and model selection.
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

Results P8-P9; Methods P40, P45; Table S1

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-fragmentiawgs2026-data-validation.

Source locator: Results P8-P9; Methods P40, P45; Table S1

Related records

Suggest a correction